[1]
Ali, M.M. , Ashraf, S.M., Mirza, U. and Fariduddin, J.M. 2022. A comparative evaluation of safety and efficacy of Rosuvastatin, Simvastatin, and Atorvastatin in patients of type 2 diabetes mellitus with dyslipidemia. International journal of health sciences. 6, S1 (Apr. 2022), 7370–7378. DOI:https://doi.org/10.53730/ijhs.v6nS1.6577.